Roivant Sciences (ROIV) Invested Capital (2022 - 2024)
Roivant Sciences' (ROIV) quarterly Invested Capital came in at $40.0 million in Q2 2024, little changed YoY from $40.0 million in Q3 2023, and little changed on a QoQ basis from $40.0 million in Q1 2024.
Roivant Sciences (ROIV) Invested Capital (2022 - 2024) Analysis & Trends
Roivant Sciences (ROIV) has 3 years of Invested Capital data on file, last reported at $40.0 million in Q2 2024.
- Quarterly Invested Capital changed 0.0% year-over-year to $40.0 million in Q2 2024, while the trailing twelve-month figure through Mar 2025 was $40.0 million (down 91.4% YoY) and the FY2024 annual result came in at $40.0 million, changed 0.0% from the prior year.
- Invested Capital steadied at $40.0 million in Q2 2024, from $40.0 million in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $195.3 million in Q4 2023 to a low of $7.3 million in Q2 2022.
- A 3-year average of $80.0 million and a median of $40.0 million in 2022 frame the typical range for Invested Capital.
- The widest YoY moves for Invested Capital: up 444.66% in 2023, down 0.0% in 2023.
- Tracing ROIV's Invested Capital over 3 years: stood at $40.0 million in 2022, then soared by 388.24% to $195.3 million in 2023, then plunged by 79.52% to $40.0 million in 2024.
- The last three Invested Capital figures came in at $40.0 million (Q2 2024), $40.0 million (Q1 2024), and $195.3 million (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 190.90 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.57 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 380.00 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 40.00 Mn |
| Mar 31, 2024 | 40.00 Mn |
| Dec 31, 2023 | 195.30 Mn |
| Sep 30, 2023 | 189.71 Mn |
| Jun 30, 2023 | 40.00 Mn |
| Mar 31, 2023 | 40.00 Mn |
| Dec 31, 2022 | 40.00 Mn |
| Sep 30, 2022 | 167.21 Mn |
| Jun 30, 2022 | 7.34 Mn |
| Mar 31, 2022 | 40.00 Mn |